Clinical Trial Update: Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Completed Phase 2 pilot clinical trial assessing the effect of omega-3 fatty acids on systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED